Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DXCM, CRWD, PATH, VERV, GTLB, and represent 60.19% of Alphabet's stock portfolio.
- Added to shares of these 5 stocks: DXCM (+$376M), RVMD (+$152M), VERV (+$25M), NMRA, Science 37 Holdings.
- Started 2 new stock positions in RVMD, Science 37 Holdings.
- Reduced shares in these 5 stocks: PATH (-$175M), OSCR (-$118M), Eqrx (-$106M), Science 37 Holdings, EVLO.
- Sold out of its positions in Eqrx, EVLO, Science 37 Holdings.
- Alphabet was a net buyer of stock by $158M.
- Alphabet has $2.2B in assets under management (AUM), dropping by 38.52%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Alphabet
Alphabet holds 44 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Dex (DXCM) | 21.2 | $457M | +462% | 3.7M | 124.09 |
|
Crowdstrike Hldgs Cl A (CRWD) | 15.2 | $328M | 1.3M | 255.32 |
|
|
Uipath Cl A (PATH) | 8.1 | $175M | -50% | 7.0M | 24.84 |
|
Verve Therapeutics (VERV) | 8.0 | $172M | +17% | 12M | 13.94 |
|
Gitlab Class A Com (GTLB) | 7.7 | $167M | 2.6M | 62.96 |
|
|
Revolution Medicines (RVMD) | 7.0 | $152M | NEW | 5.3M | 28.68 |
|
Arm Holdings Sponsored Adr (ARM) | 6.8 | $147M | 2.0M | 75.14 |
|
|
Snowflake Cl A (SNOW) | 4.9 | $107M | 536k | 199.00 |
|
|
Prime Medicine (PRME) | 4.9 | $105M | 12M | 8.86 |
|
|
Freshworks Class A Com (FRSH) | 4.4 | $95M | 4.0M | 23.49 |
|
|
Planet Labs Pbc Com Cl A (PL) | 3.7 | $79M | 32M | 2.47 |
|
|
Adagio Therapeutics (IVVD) | 1.0 | $22M | 5.7M | 3.94 |
|
|
Relay Therapeutics (RLAY) | 0.8 | $17M | 1.6M | 11.01 |
|
|
Oscar Health Cl A (OSCR) | 0.7 | $15M | -88% | 1.6M | 9.15 |
|
Rapt Therapeutics (RAPT) | 0.6 | $13M | 540k | 24.85 |
|
|
Sana Biotechnology (SANA) | 0.5 | $12M | 2.8M | 4.08 |
|
|
Lyell Immunopharma (LYEL) | 0.5 | $11M | 5.9M | 1.94 |
|
|
Beam Therapeutics (BEAM) | 0.4 | $8.8M | 322k | 27.22 |
|
|
Desktop Metal Com Cl A (DM) | 0.4 | $8.3M | 11M | 0.75 |
|
|
Monte Rosa Therapeutics (GLUE) | 0.4 | $8.3M | 1.5M | 5.65 |
|
|
Illumina (ILMN) | 0.3 | $7.4M | 54k | 139.24 |
|
|
Neumora Therapeutics (NMRA) | 0.3 | $6.9M | +102% | 405k | 17.05 |
|
Tscan Therapeutics (TCRX) | 0.3 | $6.3M | 1.1M | 5.83 |
|
|
Barinthus Biotherapeutics Pl Ads (BRNS) | 0.3 | $5.6M | 1.5M | 3.69 |
|
|
Vera Therapeutics Cl A (VERA) | 0.2 | $4.6M | 302k | 15.38 |
|
|
Autolus Therapeutics Spon Adr (AUTL) | 0.2 | $4.5M | 698k | 6.44 |
|
|
Foghorn Therapeutics (FHTX) | 0.1 | $3.2M | 501k | 6.45 |
|
|
Tenaya Therapeutics (TNYA) | 0.1 | $3.0M | 916k | 3.24 |
|
|
Benson Hill Common Stock (BHIL) | 0.1 | $2.6M | 15M | 0.17 |
|
|
Dianthus Therapeutics (DNTH) | 0.1 | $2.2M | 209k | 10.40 |
|
|
Kronos Bio (KRON) | 0.1 | $1.8M | 1.4M | 1.25 |
|
|
EXACT Sciences Corporation (EXAS) | 0.1 | $1.7M | 23k | 73.98 |
|
|
Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $1.5M | 449k | 3.32 |
|
|
Alector (ALEC) | 0.1 | $1.4M | 176k | 7.98 |
|
|
Spero Therapeutics (SPRO) | 0.1 | $1.3M | 890k | 1.47 |
|
|
Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.1M | 641k | 1.77 |
|
|
Hyperfine Com Cl A (HYPR) | 0.0 | $1.0M | 899k | 1.12 |
|
|
Science 37 Holdings Com New | 0.0 | $856k | NEW | 160k | 5.34 |
|
Cortexyme (QNCX) | 0.0 | $199k | 189k | 1.05 |
|
|
Invitae (NVTAQ) | 0.0 | $148k | 236k | 0.63 |
|
|
Fulcrum Therapeutics (FULC) | 0.0 | $96k | 14k | 6.75 |
|
|
Repligen Corporation (RGEN) | 0.0 | $69k | 383.00 | 179.80 |
|
|
Mondee Holdings Class A Com (MOND) | 0.0 | $51k | 18k | 2.76 |
|
|
Cue Health (HLTH) | 0.0 | $4.3k | 27k | 0.16 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022
- Alphabet 2014 Q1 filed Nov. 15, 2022
- Alphabet 2014 Q2 filed Nov. 15, 2022
- Alphabet 2014 Q3 filed Nov. 15, 2022
- Alphabet 2014 Q4 filed Nov. 15, 2022
- Alphabet 2015 Q1 filed Nov. 15, 2022
- Alphabet 2015 Q2 filed Nov. 15, 2022
- Alphabet 2015 Q3 filed Nov. 15, 2022
- Alphabet 2015 Q4 filed Nov. 15, 2022
- Alphabet 2016 Q1 filed Nov. 15, 2022